NYSE
ABT
Abbott Laboratories
USD 100.0050
10.7350 (+12.0253%)
Last updated: 16 Jul 2026 11:52:23 PM
DelayedDelayed at least 15 minutes
Last updated: 16 Jul 2026 11:52:23 PM (Singapore Time)
NYSEABT
Abbott Laboratories
DelayedDelayed at least 15 minutes
USD 100.0050
+12.0253%
+ USD 10.7350
Open
USD 95.2900
Prev. Close
USD 89.2700
Bid
USD 99.9900
Bid Volume
100
Ask
USD 100.0400
Ask Volume
100
Total Volume
11,497,422.48
94.9900
Day's Range
101.8699
81.9700
52 Weeks Range
137.4900
SHOW ALL KEY STATISTICS
ABT Chart
Delayed
Chart data is delayed at least 15 minutes.
Created with Highcharts 9.3.2Chart context menu20. Apr27. Apr4. May11. May18. May25. May1. Jun8. Jun15. Jun22. Jun29. Jun6. Jul13. Jul80859095100105FSM Global
Stock Information
Market Cap
USD 174.19 billion
Share Outstanding
1.74 billion
30 Days Average Volume
13.58 million
Product Currency
USD
Valuations
Earning Per Share
USD 3.730
Price-to-Earnings Ratio (PE)
25.006
Historical Avg. PE Ratio
27.914
Price-to-Book Ratio (PB)
2.987
Price-to-Sales Ratio (PS)
3.458
Price/Earnings-to-Growth Ratio
1.324
Selected Financial Data
Free Cash Flow
USD 7.40 billion
Debt-to-Equity Ratio
0.208
Current Ratio
1.576
Quick Ratio
1.183
Return On Equity (%)
13.07
Return On Assets (%)
7.76
Dividend Info
Hist. Annual Dividend
1.890
Forward Div. Yield (%)
2.820
Pay-out Ratio (%)
67.230
Last Div. Ex Date
15 Jul 2026
Next Div. Ex Date
-
Financial InformationMORE
Created with Highcharts 9.3.2Chart context menuRevenueNet Income20252024202320222021010.00B20.00B30.00B40.00B50.00B
(USD)
2025 YOY Change
2024 YOY Change
2023 YOY Change
2022 YOY Change
2021 YOY Change
Revenue
44.33B
5.67%
41.95B
4.59%
40.11B
-8.12%
43.65B
1.34%
43.08B
24.47%
Operating Income
8.05B
17.99%
6.83B
5.36%
6.48B
-22.53%
8.36B
-0.75%
8.43B
57.27%
Net Income
6.52B
-51.32%
13.40B
134.18%
5.72B
-17.45%
6.93B
-1.95%
7.07B
57.31%
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Sector
Healthcare
Industry Classification
Medical Devices
Product Type
-
Sales
USD 44.33 billion
Market Cap
USD 174.19 billion
Net Income
USD 6.52 billion
Share Outstanding
1.74 billion
Fiscal Year End
31 Dec 2026
52 Weeks Range
USD 81.9700 - USD 137.4900
Employees
115,000
30 Days Average Volume
13.58 million
Payment Method
Included under CashYes
Included under CPFIS OANo
Included under CPFIS SANo
Included under SRSNo
Upcoming Exchange HolidaysMORE
United States (US)
06Sep
Labor Day
25Nov
Thanksgiving Day
26Nov
Day after Thanksgiving (Half-Day Trading)
23Dec
Day before Christmas Day (Half-Day Trading)
24Dec
Christmas Day
Tools
newCalculatorIcon
Stock Calculator
newCalculatorIcon
Stock Returns
newScreenerSelectorIcon
Stock Screener
newCalculatorIcon
Intrinsic Value Calculator
newGainerIcon
Top Gainer Loser